Results 131 to 140 of about 3,004 (156)

[Silencing DDX17 inhibits proliferation and migration of pulmonary arterial smooth muscle cells <i>in vitro</i> by decreasing mTORC1 activity]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Deng X, Wang J, Xiong M, Wang T, Yang Y, Li, Sun X.   +6 more
europepmc   +1 more source

[Application progress of single-cell RNA sequencing technology in breast development and related diseases]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Wen S, Hu Y, Chen X, Zhou J, Li P.
europepmc   +1 more source

[Abnormal elevation of growth hormone in patients with pituitary adenoma combined with cirrhosis: A case report]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Wang Y, Duan M, Xiao J, Zhao W.
europepmc   +1 more source

[SERPINE1 overexpression promotes proliferation and paclitaxel resistance of triple-negative breast cancer cells by inducing M2 macrophage polarization]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhang Q, Liu B, Lei L, Wang Y, Zhang X, Mao Z, Tang P, Zhang J, Yang J, Peng Y, Liu Z.   +10 more
europepmc   +1 more source

[<i>Qihuang Jianpi Zishen</i> Granules improves renal damage in MRL/lpr mice by inhibiting B cell differentiation <i>via</i> the AIM2/Blimp-1/Bcl-6 axis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Cheng L, Tang Z, Li M, Chen J, Shang S, Liu S, Huang C.   +6 more
europepmc   +1 more source

[Therapeutic potential of extracellular vesicles in neurological diseases]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
DU Q, Yang C, Xia X, Wang T.
europepmc   +1 more source

[HOTAIR rs920778 single nucleotide polymorphism is associated with breast cancer susceptibility and HER2-targeted therapy resistance in Chinese population]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhang M, Sun F, Han Z, Gao Y, Luo Y.
europepmc   +1 more source

[Chinese expert consensus on the diagnosis and treatment of high-altitude polycythemia(2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Red Blood Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association, Chinese Hospital Association Hematology Branch.   +3 more
europepmc   +1 more source

[Targeting chimera technology: A new tool for undruggable in breast cancer]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Chen Z, Shen S, Song X, Xiao B.
europepmc   +1 more source

[Exogenous triggering with hCG/GnRHa improves outcomes of natural cycle IVF/ICSI in patients with diminished ovarian reserve: a propensity score matching and logistic regression analysis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Chang X, Yao N, Zhao Y, Wang Y, Wang A, Zhang H, Zhang J.   +6 more
europepmc   +1 more source